Need professional-grade analysis? Visit stockanalysis.com
$433.29M
3.40
N/A
N/A
Oramed Pharmaceuticals Inc (ORMP) trades on TA in ILS. The company is classified in the Healthcare sector under the Biotechnology industry. The stock currently trades at ILS1068.00, down 7.69% from the previous close.
Over the past year, ORMP has traded between a low of ILS700.30 and a high of ILS1157.00. The stock has gained 23.2% over this period. It is currently 7.7% below its 52-week high.
Oramed Pharmaceuticals Inc has a market capitalization of $433.29M, with a price-to-earnings ratio of 3.40.
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes. The company has license agreements with Oravax Medical Inc. to commercialize oral vaccines for COVID-19 and other novel coronaviruses. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York, New York.